Mingxing Zhou

Title: The Innovations of Mingxing Zhou

Introduction

Mingxing Zhou is a prominent inventor based in Fort Collins, CO (US). He has made significant contributions to the field of pharmaceutical delivery systems, holding a total of 17 patents. His work focuses on innovative solutions that enhance the efficacy and safety of drug delivery.

Latest Patents

One of his latest patents is an injectable flowable composition comprising buprenorphine. This invention is directed towards a buprenorphine sustained release delivery system capable of delivering buprenorphine, a metabolite, or a prodrug thereof for a duration of about 14 days to about 3 months. The system includes a flowable composition and a solid implant for the sustained release of buprenorphine. The implant is produced from the flowable composition, providing in situ 1-month and 3-month release profiles characterized by exceptionally high bioavailability and minimal risk of permanent tissue damage, typically with no risk of muscle necrosis.

Career Highlights

Mingxing Zhou has worked with notable companies in the pharmaceutical industry, including Indivior UK Limited and Atrix Laboratories, Inc. His experience in these organizations has contributed to his expertise in drug delivery systems and innovation in the field.

Collaborations

Throughout his career, Mingxing Zhou has collaborated with esteemed colleagues such as Richard L Norton and Andrew Watkins. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Mingxing Zhou's contributions to the field of pharmaceutical innovations are noteworthy. His inventions, particularly in the area of sustained release delivery systems, demonstrate his commitment to improving patient care through advanced technology. His work continues to influence the industry and pave the way for future innovations.